Structural basis of SIRT7 nucleosome engagement and substrate specificity

被引:0
|
作者
Moreno-Yruela, Carlos [1 ]
Ekundayo, Babatunde E. [2 ,3 ]
Foteva, Polina N. [1 ]
Ni, Dongchun [2 ,3 ]
Calvino-Sanles, Esther [1 ]
Stahlberg, Henning [2 ,3 ]
Fierz, Beat [1 ]
机构
[1] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn ISIC, Sch Basic Sci SB, Lab Biophys Chem Macromol LCBM, Lausanne, Switzerland
[2] Ecole Polytech Fed Lausanne, Inst Phys IPHYS, Sch Basic Sci SB, Lab Biol Electron Microscopy LBEM, Lausanne, Switzerland
[3] Univ Lausanne, Fac Biol & Med FBM, Dept Fundamental Microbiol DMF, Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
MECHANISM; SIRTUINS; RECONSTITUTION; ACETYLATION; INHIBITORS; COMPLEXES; INSIGHTS; FEATURES; REVEALS; DNA;
D O I
10.1038/s41467-025-56529-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Chromatin-modifying enzymes target distinct residues within histones to finetune gene expression profiles. SIRT7 is an NAD+-dependent deacylase often deregulated in cancer, which deacetylates either H3 lysine 36 (H3K36) or H3K18 with high specificity within nucleosomes. Here, we report structures of nucleosome-bound SIRT7, and uncover the structural basis of its specificity towards H3K36 and K18 deacylation, combining a mechanism-based cross-linking strategy, cryo-EM, and enzymatic and cellular assays. We show that the SIRT7 N-terminus represents a unique, extended nucleosome-binding domain, reaching across the nucleosomal surface to the acidic patch. The catalytic domain binds at the H3-tail exit site, engaging both DNA gyres of the nucleosome. Contacting H3K36 versus H3K18 requires a change in binding pose, and results in structural changes in both SIRT7 and the nucleosome. These structures reveal the basis of lysine specificity, allowing us to engineer SIRT7 towards enhanced H3K18ac selectivity, and provides a basis for small molecule modulator development.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Sirt7 promotes adipogenesis by binding to and inhibiting Sirt1
    Eva Bober
    Jian Fang
    Christian Smolka
    Alessandro Ianni
    Olesya Vakhrusheva
    Marcus Krüger
    Thomas Braun
    BMC Proceedings, 6 (Suppl 3)
  • [32] ‘SIRT8’ expressed in thyroid cancer is actually SIRT7
    R Frye
    British Journal of Cancer, 2002, 87 : 1479 - 1479
  • [33] Structural Basis for the Dual Substrate Specificity of DOCK7 Guanine Nucleotide Exchange Factor
    Kukimoto-Niino, Mutsuko
    Tsuda, Kengo
    Ihara, Kentaro
    Mishima-Tsumagari, Chiemi
    Honda, Keiko
    Ohsawa, Noboru
    Shirouzu, Mikako
    STRUCTURE, 2019, 27 (05) : 741 - +
  • [34] Advances in Cellular Characterization of the Sirtuin lsoform, SIRT7
    Wu, Di
    Li, Yinglu
    Zhu, Kathy S.
    Wang, Haiying
    Zhu, Wei-Guo
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [35] Stressed SIRT7: facing a crossroad of senescence and immortality
    Liu, Jun-Ping
    Chen, Ruping
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2015, 42 (06): : 567 - 569
  • [36] Sirt7 Regulates Tgfb Signaling by Modulating Autophagy
    Araki, Satoshi
    Izumiya, Yasuhiro
    Hanatani, Shinsuke
    Kimura, Yuichi
    Onoue, Yoshiro
    Braun, Thomas
    Bober, Eva
    Ogawa, Hisao
    CIRCULATION, 2014, 130
  • [37] SIRT7: the seventh key to unlocking the mystery of aging
    Raza, Umar
    Tang, Xiaolong
    Liu, Zuojun
    Liu, Baohua
    PHYSIOLOGICAL REVIEWS, 2024, 104 (01) : 253 - 280
  • [38] Role of the epigenetic factor Sirt7 in neuroinflammation and neurogenesis
    Burg, Nicolas
    Bittner, Stefan
    Ellwardt, Erik
    NEUROSCIENCE RESEARCH, 2018, 131 : 1 - 9
  • [39] The Emerging Role of SIRT7 in Glucose and Lipid Metabolism
    Yamagata, Kazuya
    Mizumoto, Tomoya
    Yoshizawa, Tatsuya
    CELLS, 2024, 13 (01)
  • [40] Clinicopathological and molecular analysis of SIRT7 in hepatocellular carcinoma
    Yanai, Masae
    Kurata, Morito
    Muto, Yutaka
    Iha, Hiroto
    Kanao, Toshinori
    Tatsuzawa, Anna
    Ishibashi, Sachiko
    Ikeda, Masumi
    Kitagawa, Masanobu
    Yamamoto, Kouhei
    PATHOLOGY, 2020, 52 (05) : 529 - 537